Sportron International "cannot contract out its ultimate responsibility to ensure that the dietary supplement it places into commerce" is compliant, and Absonutrix failed "to conduct at least one appropriate test or examination to verify the identity of a dietary ingredient," say FDA warning letters listing some of the most frequently noted problems found in GMP and labeling inspections.
The US Food and Drug Administration's latest warnings in the dietary supplement industry included one to another own-label marketer and one noting another example of a firm not conducting ingredient identity tests.
A "firm may contract out certain dietary supplement manufacturing, packaging, and/or labeling operations," stated the FDA's Office of Human and...